These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 16523901

  • 1. [Effects of sex steroid hormones on renal functions in molecular biology].
    Tamaya T.
    Nihon Rinsho; 2006 Feb; 64 Suppl 2():271-5. PubMed ID: 16523901
    [No Abstract] [Full Text] [Related]

  • 2. A clinical approach in regression of glomerulosclerosis.
    Stoian M, Radulian G, Chiţac D, Simion E, Stoica V.
    Rom J Intern Med; 2007 Feb; 45(2):215-8. PubMed ID: 18333378
    [Abstract] [Full Text] [Related]

  • 3. [Vasoactive peptides and the development of renal sclerosis: contribution of transgenes].
    Dussaule JC, Boffa JJ, Tharaux PL, Flamant M, Fakhouri F, Chatziantoniou C.
    J Soc Biol; 2002 Feb; 196(4):275-80. PubMed ID: 12645295
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Proteases and antiproteases in the progression of chronic renal insufficiency lesions. The role of the tissue renin-angiotensin system and the renin receptor].
    Nguyen G, Burcklé C, Sraer JD.
    J Soc Biol; 2002 Feb; 196(4):281-4. PubMed ID: 12645296
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Angiotensin as inducer of plasminogen activator inhibitor-1 and fibrosis.
    Ma LJ, Fogo AB.
    Contrib Nephrol; 2001 Feb; (135):161-70. PubMed ID: 11705282
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Primary and secondary glomerular diseases].
    Birck R, Banas B.
    Dtsch Med Wochenschr; 2011 Apr; 136(14):703-5. PubMed ID: 21448831
    [No Abstract] [Full Text] [Related]

  • 17. Obesity-associated activation of angiotensin and endothelin in the cardiovascular system.
    Barton M, Carmona R, Ortmann J, Krieger JE, Traupe T.
    Int J Biochem Cell Biol; 2003 Jun; 35(6):826-37. PubMed ID: 12676169
    [Abstract] [Full Text] [Related]

  • 18. Gender differences in the renin-angiotensin and nitric oxide systems: relevance in the normal and diseased kidney.
    McGuire BB, Watson RW, Pérez-Barriocanal F, Fitzpatrick JM, Docherty NG.
    Kidney Blood Press Res; 2007 Jun; 30(2):67-80. PubMed ID: 17268203
    [Abstract] [Full Text] [Related]

  • 19. The intrarenal renin-angiotensin system.
    Burns KD, Homma T, Harris RC.
    Semin Nephrol; 1993 Jan; 13(1):13-30. PubMed ID: 8434183
    [Abstract] [Full Text] [Related]

  • 20. Biology and functions of renal receptors for angiotensin II and its active fragments.
    Ardaillou R, Chansel D, Chatziantoniou C, Dussaule JC.
    Adv Nephrol Necker Hosp; 1998 Jan; 28():225-57. PubMed ID: 9889993
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.